These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 2834672)
1. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission. Savasta M; Dubois A; Benavidès J; Scatton B Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672 [TBL] [Abstract][Full Text] [Related]
2. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609 [TBL] [Abstract][Full Text] [Related]
3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
4. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway. Ariano MA Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Graham WC; Crossman AR; Woodruff GN Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410 [TBL] [Abstract][Full Text] [Related]
6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Kerkerian L; Salin P; Nieoullon A Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926 [TBL] [Abstract][Full Text] [Related]
8. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053 [TBL] [Abstract][Full Text] [Related]
9. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295 [TBL] [Abstract][Full Text] [Related]
10. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation. Korf J; Sebens JB J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979 [TBL] [Abstract][Full Text] [Related]
11. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. MacKenzie RG; Zigmond MJ J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330 [TBL] [Abstract][Full Text] [Related]
13. Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat. Kujirai K; Przedborski S; Kostic V; Jackson-Lewis V; Fahn S; Cadet JL Brain Res Bull; 1990 Nov; 25(5):703-9. PubMed ID: 2149666 [TBL] [Abstract][Full Text] [Related]
14. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors. Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822 [TBL] [Abstract][Full Text] [Related]
15. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution. Caboche J; Rogard M; Besson MJ Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802 [TBL] [Abstract][Full Text] [Related]
16. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo. Leslie CA; Bennett JP Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025 [TBL] [Abstract][Full Text] [Related]
17. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
18. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function. Broaddus WC; Bennett JP Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042 [TBL] [Abstract][Full Text] [Related]
19. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors. Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392 [TBL] [Abstract][Full Text] [Related]
20. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Beckstead RM Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]